Skip to Content

427 MYLAN (Sulindac 150 mg)

Pill with imprint 427 MYLAN is Yellow, Round and has been identified as Sulindac 150 mg. It is supplied by Mylan Pharmaceuticals Inc..

Sulindac is used in the treatment of familial adenomatous polyposis; ankylosing spondylitis; bursitis; gout, acute; juvenile rheumatoid arthritis (and more), and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Sulindac 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 427 MYLAN

Sulindac

Imprint:
427 MYLAN
Strength:
150 mg
Color:
Yellow
Size:
10.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:
silicon dioxide
croscarmellose sodium
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide